rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-3-31
|
pubmed:abstractText |
Induction chemotherapy (IC) followed by concomitant chemoradiotherapy (CCRT) has the potential of being an ideal multi-modality approach for improving the prognosis of patients with squamous cell carcinoma of the head and neck (SSCHN).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0250-7005
|
pubmed:author |
pubmed-author:AthanassiouEleniE,
pubmed-author:BamiasAristotelisA,
pubmed-author:BobosMattheosM,
pubmed-author:FountzilasGeorgeG,
pubmed-author:Kalogera-FountzilaAnnaA,
pubmed-author:KalogerasKonstantine TKT,
pubmed-author:KarayannopoulouGeorgiaG,
pubmed-author:KosmidisParisP,
pubmed-author:MisailidouDespinaD,
pubmed-author:PapakostasPavlosP,
pubmed-author:TolisChristosC,
pubmed-author:TsekerisPeriklisP,
pubmed-author:VamvoukaChrysanthiC,
pubmed-author:ZamboglouNikolaosN,
pubmed-author:ZaramboukasThomasT
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
529-38
|
pubmed:meshHeading |
pubmed-meshheading:19331199-Adult,
pubmed-meshheading:19331199-Aged,
pubmed-meshheading:19331199-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19331199-Carcinoma, Squamous Cell,
pubmed-meshheading:19331199-Cisplatin,
pubmed-meshheading:19331199-Combined Modality Therapy,
pubmed-meshheading:19331199-Disease-Free Survival,
pubmed-meshheading:19331199-Female,
pubmed-meshheading:19331199-Gene Amplification,
pubmed-meshheading:19331199-Genes, erbB-2,
pubmed-meshheading:19331199-Head and Neck Neoplasms,
pubmed-meshheading:19331199-Humans,
pubmed-meshheading:19331199-In Situ Hybridization, Fluorescence,
pubmed-meshheading:19331199-Male,
pubmed-meshheading:19331199-Middle Aged,
pubmed-meshheading:19331199-Remission Induction,
pubmed-meshheading:19331199-Taxoids
|
pubmed:year |
2009
|
pubmed:articleTitle |
Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck.
|
pubmed:affiliation |
Department of Medical Oncology, "Papageorgiou" Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. fountzil@med.auth.gr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|